Clinical aspects of myasthenia explained

References

• Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity. Lancet Neurol. 2009; 8 5: 475–490.
   PubMed Web of Science ®Google Scholar
• Heldal AT, Owe JF, Gilhus NE, Romi F. Seropositive myasthenia gravis: A nationwide epidemiologic study. Neurology. 2009; 73 2: 150–151.
   PubMed Web of Science ®Google Scholar
• Vincent A, Leite MI. Neuromuscular junction autoimmune disease: Muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol. 2005; 18 5: 519–525.
   Google Scholar
• Delgado JC, Hameed A, Yunis JJ, Bhol K, Rojas AI, Rehman SB, Khan AA, Ahmad M, Alper CA, Ahmed AR, Yunis EJ. Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Hum Immunol. 1997; 57 2: 110–119.
   Google Scholar
• Wirtz PW, Nijnuis MG, Sotodeh M, Willems LNA, Brahim JJ, Putter H, Wintzen AR, Verschuuren JJ. The epidemiology of myasthenia gravis, Lambert–Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland. J Neurol. 2003; 250 6: 698–701.
   Google Scholar
• Vincent A, Clover L, Buckley C, Grimley EJ, Rothwell PM. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psych. 2003; 74 8: 1105–1108.
   PubMed Web of Science ®Google Scholar
• Niks EH, Kuks JB, Verschuuren JJ. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands. J Neurol Neurosurg Psych. 2007; 78 4: 417–418.
   Google Scholar
• Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain. 2003; 126 Pt 10: 2304–2311.
   Google Scholar
• Gilhus NE. Autoimmune myasthenia gravis. Expert Rev Neurother. 2009; 9 3: 351–358.
   PubMed Web of Science ®Google Scholar
• Vincent A. Autoimmune disorders of the neuromuscular junction. Neurol India. 2008; 56 3: 305–313.
   Google Scholar
• Chaudhuri A, Behan PO. Myasthenic crisis. QJM Inter J Med. 2009; 102 2: 97–107.
   Google Scholar
• Chiang LM, Darras BT, Kang PB. Juvenile myasthenia gravis. Muscle Nerve. 2009; 39 4: 423–431.
   Google Scholar
• Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain. 2006; 129 Pt 6: 1481–1492.
   Google Scholar
• Leite MI, Strobel P, Jones M, Micklem K, Moritz R, Gold R, Niks EH, Berrih-Aknin S, Scaravilli F, Canelhas A, Marx A, Newsom-Davis J, Willcox N, Vincent A. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol. 2005; 57 3: 444–448.
   PubMed Web of Science ®Google Scholar
• Saka E, Topcuoglu MA, Akkaya B, Galati A, Onal MZ, Vincent A. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology. 2005; 65 5: 782–783.
   Google Scholar
• Niks EH, Kuks JB, Roep BO, Haasnoot GW, Verduijn W, Ballieux BE, De Baets MH, Vincent A, Verschuuren JJ. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5. Neurology. 2006; 66 11: 1772–1774.
   PubMed Web of Science ®Google Scholar
• Niks EH, van Leeuwen Y, Leite MI, Dekker FW, Wintzen AR, Wirtz PW, Vincent A, van Tol MJD, Zijde CMJV, Verschuuren JJGM. Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1. J Neuroimmunol. 2008; 195 1–2: 151–156.
   PubMed Web of Science ®Google Scholar
• McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, Vincent A. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004; 55 4: 580–584.
   PubMed Web of Science ®Google Scholar
• Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A. IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis. Brain. 2008; 131 Pt 7: 1940–1952.
   Google Scholar
• Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert–Eaton myasthenic syndrome. J Neurol Sci. 1997; 147 1: 35–42.
   PubMed Web of Science ®Google Scholar
• Oneill JH, Murray NMF, Newsomdavis J. The Lambert–Eaton myasthenic syndrome—A review of 50 cases. Brain. 1988; 111:577–596.
   PubMedGoogle Scholar
• Wirtz PW, Sotodeh M, Nijnuis M, van Doorn PA, van Engelen BGM, Hintzen RQ, de Kort PLM, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert–Eaton myasthenic syndrome. J Neurol Neurosurg Psych. 2002; 73 6: 766–768.
   Google Scholar
• Titulaer MJ, Verschuuren JJGM. Lambert–Eaton myasthenic syndrome – Tumor versus nontumor forms. Ann N Y Acad Sci. 2008; 1132:129–134.
   PubMed Web of Science ®Google Scholar
• Maddison P, Newsom-Davis J, Mills KR, Souhami RL. Favourable prognosis in Lambert–Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet. 1999; 353 9147: 117–118.
   PubMed Web of Science ®Google Scholar
• Oskoui M, Jacobson L, Chung WK, Haddad J, Vincent A, Kaufmann P, De Vivo DC. Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis. Neurology. 2008; 71 24: 2010–2012.
   Google Scholar
• Niks EH, Verrips A, Semmekrot BA, Prick MJ, Vincent A, van Tol MJ, Jol-van der Zijde CM, Verschuuren JJ. A transient neonatal myasthenic syndrome with anti-musk antibodies. Neurology. 2008; 70 14: 1215–1216.
   Google Scholar
• Reuner U, Kamin G, Ramantani G, Reichmann H, Dinger J. Transient neonatal Lambert–Eaton syndrome. J Neurol. 2008; 255 11: 1827–1828.
   Google Scholar
• Riemersma S, Vincent A, Beeson D, Newland C, Hawke S, Vernet-der GB, Eymard B, Newsom-Davis J. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest. 1996; 98 10: 2358–2363.
   Google Scholar
• Bever CTJr, Aquino AV, Penn AS, Lovelace RE, Rowland LP. Prognosis of ocular myasthenia. Ann Neurol. 1983; 14 5: 516–519.
   PubMed Web of Science ®Google Scholar
• Sommer N, Melms A, Weller M, Dichgans J. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects. Doc Ophthalmol. 1993; 84 4: 309–333.
   Google Scholar
• Cucurachi L, Cattaneo L, Gemignani F, Pavesi G. Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement. Neurol Sci. 2009; 30:343–344.
   Google Scholar
• Guglieri M, Straub V, Bushby K, Lochmuller H. Limb-girdle muscular dystrophies. Curr Opin Neurol. 2008; 21 5: 576–584.
   PubMed Web of Science ®Google Scholar
• Shih HP, Gross MK, Kioussi C. Muscle development: Forming the head and trunk muscles. Acta Histochem. 2008; 110 2: 97–108.
   Google Scholar
• Wai Yu, Man CY, Chinnery PF, Griffiths PG. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord. 2005; 15 1: 17–23.
   Google Scholar
• Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Andrade FH. Extraocular muscle is defined by a fundamentally distinct gene expression profile. Proc Natl Acad Sci USA. 2001; 98 21: 12062–12067.
   PubMed Web of Science ®Google Scholar
• Groen WB, Leen WG, Vos AM, Cruysberg JR, van Doorn PA, van Engelen BG. Ptosis as a feature of late-onset glycogenosis type II. Neurology. 2006; 67 12: 2261–2262.
   Google Scholar
• Rodolico C, Toscano A, Autunno M, Messina S, Nicolosi C, Aguennouz M, Laura M, Girlanda P, Messina C, Vita G. Limb-girdle myasthenia: Clinical, electrophysiological and morphological features in familial and autoimmune cases. Neuromusc Disord. 2002; 12 10: 964–969.
   Google Scholar
• Oh SJ, Kuruoglu R. Chronic limb-girdle myasthenia gravis. Neurology. 1992; 42 6: 1153–1156.
   Google Scholar
• Nations SP, Wolfe GI, Amato AA, Jackson CE, Bryan WW, Barohn RJ. Distal myasthenia gravis. Neurology. 1999; 52 3: 632–634.
   Google Scholar
• Mihaylova V, Muller JS, Vilchez JJ, Salih MA, Kabiraj MM, D'Amico A, Bertini E, Wolfle J, Schreiner F, Kurlemann G, Rasic VM, Siskova D, Colomer J, Herczegfalvi A, Fabriciova K, Weschke B, Scola R, Hoellen F, Schara U, Abicht A, Lochmuller H. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes. Brain. 2008; 131 Pt 3: 747–759.
   Google Scholar
• Wintzen AR, Plomp JJ, Molenaar PC, van Dijk JG, van Kempen GT, Vos RM, Wokke JH, Vincent A. Acquired slow-channel syndrome: A form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel. Ann Neurol. 1998; 44 4: 657–664.
   PubMed Web of Science ®Google Scholar
• Scola RH, Werneck LC, Iwamoto FM, Comerlato EA, Kay CK. Acquired slow-channel syndrome. Muscle Nerve. 2000; 23 10: 1582–1585.
   Google Scholar
• Bady B, Chauplannaz G, Carrier H. Congenital Lambert–Eaton myasthenic syndrome. J Neurol Neurosurg Psych. 1987; 50 4: 476–478.
   Google Scholar
• Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B, Beyring R, Robb S, Kirkham FJ, Engel AG. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA. 2001; 98 4: 2017–2022.
   PubMed Web of Science ®Google Scholar
• Conomy JP, Levinsohn M, Fanaroff A. Familial infantile myasthenia gravis: A cause of sudden death in young children. J Pediatr. 1975; 87 3: 428–430.
   Google Scholar
• Maselli RA, Chen D, Mo D, Bowe C, Fenton G, Wollmann RL. Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetylcholine resynthesis. Muscle Nerve. 2003; 27 2: 180–187.
   Google Scholar
• Maselli RA, Kong DZ, Bowe CM, McDonald CM, Ellis WG, Agius MA, Gomez CM, Richman DP, Wollmann RL. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology. 2001; 57 2: 279–289.
   Google Scholar
• Walls TJ, Engel AG, Nagel AS, Harper CM, Trastek VF. Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release. Ann N Y Acad Sci. 1993; 681:461–468.
   Google Scholar
• Maselli RA, Ng JJ, Anderson JA, Cagney O, Arredondo J, Williams C, Wessel HB, Abdel-Hamid H, Wollmann RL. Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome. J Med Genet. 2009; 46 3: 203–208.
   PubMed Web of Science ®Google Scholar
• Richard P, Gaudon K, Haddad H, Ben Ammar A, Genin E, Bauche S, Paturneau-Jouas M, Muller JS, Lochmueller H, Grid D, Hamri A, Nouioua S, Tazir M, Mayer M, Desnuelle C, Barois A, Chabrol B, Pouget J, Koenig J, Gouider-Khouja N, Hentati F, Eymard B, Hantai D. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa. Neurology. 2008; 71 24: 1967–1972.
   Google Scholar
• Shen XM, Ohno K, Fukudome T, Tsujino A, Brengman JM, De Vivo DC, Packer RJ, Engel AG. Congenital myasthenic syndrome caused by low-expressor fast-channel AChR delta subunit mutation. Neurology. 2002; 59 12: 1881–1888.
   Google Scholar
• Webster R, Brydson M, Croxen R, Newon-Davis J, Vincent A, Beeson D. Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome. Neurology. 2004; 62 7: 1090–1096.
   Google Scholar
• Burke G, Cossins J, Maxwell S, Owens G, Vincent A, Robb S, Nicolle M, Hilton-Jones D, Newsom-Davis J, Palace J, Beeson D. Rapsyn mutations in hereditary myasthenia—Distinct early- and late-onset phenotypes. Neurology. 2003; 61 6: 826–828.
   Google Scholar
• Muller JS, Mildner G, Muller-Felber W, Schara U, Krampfl K, Petersen B, Petrova S, Stucka R, Mortier W, Bufler J, Kurlemann G, Huebner A, Merlini L, Lochmuller H, Abicht A. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients. Neurology. 2003; 60 11: 1805–1810.
   Google Scholar
• Tsujino A, Maertens C, Ohno K, Shen XM, Fukuda T, Harper CM, Cannon SC, Engel AG. Myasthenic syndrome caused by mutation of the SCN4A sodium channel. Proc Natl Acad Sci USA. 2003; 100 12: 7377–7382.
   PubMed Web of Science ®Google Scholar
• Banwell BL, Russel J, Fukudome T, Shen XM, Stilling G, Engel AG. Myopathy, myasthenic syndrome, and epidermolysis bullosa simplex due to plectin deficiency. J Neuropathol Exp Neurol. 1999; 58 8: 832–846.
   PubMed Web of Science ®Google Scholar
• Palace J, Lashley D, Newsom-Davis J, Cossins J, Maxwell S, Kennett R, Jayawant S, Yamanashi Y, Beeson D. Clinical features of the DOK7 neuromuscular junction synaptopathy. Brain. 2007; 130 Pt 6: 1507–1515.
   Google Scholar
• Selcen D, Milone M, Shen XM, Harper CM, Stans AA, Wieben ED, Engel AG. Dok-7 myasthenia: Phenotypic and molecular genetic studies in 16 patients. Ann Neurol. 2008; 64 6: S153–S154.
   Google Scholar